Deerfield Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,199
Closed -$360K 138
2025
Q4
$360K Sell
2,199
-10,710
-83% -$1.68M ﹤0.01% 136
2025
Q3
$1.73M Buy
12,909
+11,281
+693% +$1.37M 0.03% 105
2025
Q2
$202K Buy
+1,628
New +$207K ﹤0.01% 108
2024
Q4
Sell
-1,418
Closed -$211K 361
2024
Q3
$211K Sell
1,418
-1,944
-58% -$279K ﹤0.01% 420
2024
Q2
$424K Buy
+3,362
New +$527K 0.01% 292

Other funds holding RGEN

Deerfield Management's RGEN Position: Q1 2026 in Review

Deerfield Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 2,199 shares — an estimated $360K sold.

Deerfield Management first reported a position in RGEN in Q2 2024 and held it in 5 quarters. The position peaked at $1.73M in Q3 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Deerfield Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 2,199 Repligen shares in Q1 2026, an estimated $360K.
  • Deerfield Management first reported a position in Repligen in Q2 2024 and held it in 5 quarters.
  • Deerfield Management's Repligen position peaked at $1.73M in Q3 2025.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.